Pernix Therapeutics Overcomes Challenge to Treximet® ‘183 Patent
May 09, 2016 08:00 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced that on May 6, 2016, the Patent Trial and...
Pernix Therapeutics Reports First Quarter 2016 Financial Results and Business Update
May 05, 2016 08:00 ET
|
Pernix Therapeutics Holdings, Inc.
Pernix Prescriptions DirectTM Achieves Increased Penetration MORRISTOWN, N.J., May 05, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), a...